NDC 68071-3452-06 - Glyburide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3452
- Requested NDC
- 68071-3452-06
- Package NDCs from labels
- 68071-3452-3, 68071-3452-6, 68071-3452-06
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2026-01-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYBURIDE TABLETS, USP For Oral Use 1.25, 2.5, and 5 mg | NuCare Pharmaceuticals,Inc. | 2026-01-16 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-3452-3 | 2026-01-16 | C162847 | 48780-1 | 2cef2736-7c4c-d83d-e063-dadaa90ab31f | GLYBURIDE TABLETS, USP For Oral Use 1.25, 2.5, and 5 mg |
| 68071-3452-3 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-7c4c-d83d-e063-dadaa90ab31f | GLYBURIDE TABLETS, USP For Oral Use 1.25, 2.5, and 5 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3452-3 | Glyburide | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 68071-3452-6 | Glyburide | 60 in 1 BOTTLE | TABLET | 60 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3452 | GLYBURIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 1 | Current NDC, 2 package rows | 20230707_ffd31d06-6011-34e2-e053-6394a90a437f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glyburide | GLYBURIDE | TEVA Pharmaceuticals USA Inc | 50d16f1d-c814-4411-8749-62561321ecce | 2021-07-01 | Warnings, Adverse reactions | 310537 197737 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | Proficient Rx LP | ec45f0d8-cab8-4822-895b-17bb443a4f98 | 2019-11-01 | Warnings, Adverse reactions | 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | Proficient Rx LP | b292cb9b-7348-4c07-a871-bc091229fdf8 | 2019-11-01 | Adverse reactions | 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | Proficient Rx LP | 240c3ac6-9aab-4185-994e-a0254e3aeb61 | 2019-11-01 | Adverse reactions | 310537 SX6K58TVWC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.